QIAGEN powered by
Streamlined bioinformatics for RNA sequencing of liquid biopsies

QIAGEN Digital Insights Thursday, April 14, 2016

New, powerful bioinformatics tool: The RNA-Seq Explorer Solution Today we announced our new RNA-Seq Explorer Solution — a powerful bioinformatics…

A retrospective look at cancer research efforts

QIAGEN Digital Insights Thursday, April 14, 2016

From IPA and Ingenuity® Variant Analysis™ to Biomedical Genomics Workbench, we’re honored to see that our products are on the…

CTCs as prognostic markers for metastatic breast cancer

QIAGEN Digital Insights Tuesday, April 12, 2016

Circulating tumor cells (CTCs) are tumor cells circulating freely in the peripheral blood of patients. The characterization of CTCs is…

Liquid biopsies show promise

QIAGEN Digital Insights Tuesday, April 5, 2016

Liquid biopsies show promise for cancer research, but technical challenges remain Preparing for this year’s annual meeting of the American…

Improve variant analysis and case solve rate

QIAGEN Digital Insights Wednesday, March 30, 2016

Looking back at ACMG 2016 where speakers looked ahead to improved variant analysis Inspiring talks at ACMG We recently attended the…

Bioinformatics and disease: A growing relationship

QIAGEN Digital Insights Tuesday, March 8, 2016

Recently the Journal of Precision Medicine ran a compelling article by Valentin Barsan, MD, about the increasing relevance of next-generation…

Meet us at ACMG 2016

Anja Lykkebak Tuesday, March 1, 2016

The 2016 American College of Medical Genetics and Genomics (ACMG) Annual Meeting takes place on March 9-11, in Tampa, Florida….

Raising the profile of rare disease

QIAGEN Digital Insights Monday, February 29, 2016

Living with a rare disease is often lonely and isolating for patients and caregivers alike. Through our work with researchers…

Circulating cfDNA purification, sequencing and data interpretation

QIAGEN Digital Insights Monday, February 29, 2016

Webinar series on liquid biopsyCirculating cell-free DNA purification, sequencing and data interpretation Identification and monitoring of cancer mutations of circulating…

How secure is your bioinformatics data?

QIAGEN Digital Insights Tuesday, February 23, 2016

As the production of genome data and variant interpretation information skyrockets, scientists and clinicians are asking compelling new questions about…

Scalable NGS-based test interpretation in oncology

QIAGEN Digital Insights Monday, February 22, 2016

We were honored to take part in last month’s Personalized Medicine World Conference (PMWC), where speakers and attendees focused on…

QIAGEN teams up with 10x Genomics

QIAGEN Digital Insights Tuesday, February 16, 2016

At the AGBT conference in Orlando we announced a new collaboration with 10x Genomics to co-market and co-develop NGS, single-cell…

This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.